Takashi Nakano

6PUBLICATIONS
15CO-AUTHORS
Gene and molecular therapyHaematologyNanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2025
Qualification Criteria of Gene Therapy for Haemophilia-Opinion of the EAHAD Gene Therapy Working Group.

Wolfgang Miesbach, Ana Boban, Pratima Chowdary

|Nov 20, 2024
UKHCDO gene therapy taskforce: Guidance for implementation of haemophilia gene therapy into routine clinical practice for adults.

Pratima Chowdary, Beatriz Duran, Paul Batty

|Jul 10, 2024
Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A.

Pål André Holme, Jan Blatný, Pratima Chowdary

|Sep 20, 2023
Cases of less-than-expected FVIII activity in previously treated patients during post-marketing surveillance of N8-GP.

Johannes Oldenburg, Gary Benson, Pratima Chowdary

|Feb 19, 2022
Anti-CD20-atezolizumab-polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma.

Max S Topp, Herbert Eradat, Axel Florschütz

|Sep 07, 2020
Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study.

Takashi Nakano, Kozo Kuribayashi, Masashi Kondo

Pageof 1